Human genome research platform
Repositive has raised €2.9M across 1 funding round from 4 investors, most recently a Series A round in Apr 2017. Based in UK; active in Software and Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-04-05 | Series A | €2.9M |
| Amadeus Capital Partners,Ananda Ventures,Force Over Mass Capital,Jonathan Milner. |
| View deal → |
